Epitope-based identification of SARS-CoV-2-neutralizing antibodies from convalescent patients
Feb. 21, 2023
The emergence of new variants of concern (VOCs) of SARS-CoV-2 may limit the efficacy of monoclonal antibodies and vaccines currently used in the clinic.
